Hearps AC, Angelovich TA, Trevillyan JM, Wong ME, et al. Rosuvastatin therapy in people with HIV at intermediate cardiovascular risk does not decrease biomarkers of inflammation and immune activation. J Infect Dis 2020 Dec 22. pii: 6044066. doi: 10.1093.
PMID: 33350447